News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Asuragen, Inc. Appoints Lyle Arnold, Ph.D., to Board of Directors
March 30, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a leader in molecular diagnostic development, announced today the appointment of Lyle Arnold, Ph.D., to its board of directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Earnings
Takeda Pledges $30B in U.S., Argues Against Trump’s ‘Most Favored Nations’ Proposal
May 8, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs
May 8, 2025
·
2 min read
·
Tristan Manalac
Cancer
C4 Therapeutics Shelves BRAF Blocker, Goes All-In on Multiple Myeloma Drug
May 7, 2025
·
1 min read
·
Tristan Manalac
Gene therapy
CRISPR’s Casgevy on the Rise With More Gene Therapy Proof of Concept To Come in 2025
May 7, 2025
·
4 min read
·
Annalee Armstrong
